Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Kymera Therapeutics, Inc. - Common Stock (NQ:KYMR)

87.53 +1.45 (+1.68%)

Streaming Delayed Price Updated: 9:41 AM EDT, May 11, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	21,505
Open	85.98
Bid (Size)	86.20 (100)
Ask (Size)	87.97 (100)
Prev. Close	86.08
Today's Range	85.84 - 87.79
52wk Range	28.06 - 103.00
Shares Outstanding	55,307,775
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kymera Therapeutics (NASDAQ:KYMR) Soars on Q1 2026 Revenue and EPS Beat ↗

April 30, 2026

Via Chartmill

Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗

March 19, 2026

Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified clinical pipeline.

Via The Motley Fool

Performance

YTD	+20.3%	+20.3%
1 Month	+2.9%	+2.9%
3 Month	+10.8%	+10.8%
6 Month	+42.9%	+42.9%
1 Year	+172.1%	+172.1%

More News

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗

March 09, 2026

Via The Motley Fool

Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗

March 06, 2026

Via The Motley Fool

Kymera Therapeutics Inc (NASDAQ:KYMR) Stock Falls 6.6% After Q4 2025 Earnings Miss and Extended Clinical Timelines ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗

March 05, 2026

Via The Motley Fool

Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗

March 04, 2026

Via The Motley Fool

Kymera (KYMR) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗

February 25, 2026

Via The Motley Fool

Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗

February 25, 2026

Via The Motley Fool

Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗

February 25, 2026

Via The Motley Fool

Kymera Stock Up 130% as $135 Million Buy Boosts Immunology Bet ↗

February 23, 2026

Via The Motley Fool

Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗

February 17, 2026

Via The Motley Fool

Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks ↗

January 01, 2026

Via MarketBeat

Streaming Wars Go Hostile Just as Wall Street Braces for the Fed ↗

December 09, 2025

Via Chartmill

What's going on in today's session ↗

December 08, 2025

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

December 08, 2025

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

December 08, 2025

Via Chartmill

Why Is KYMR Stock Up 30% Pre-Market Today? ↗

December 08, 2025

Via Stocktwits

These stocks are moving in today's after hours session ↗

December 05, 2025

Via Chartmill

Kymera (KYMR) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

10 Analysts Have This To Say About Kymera Therapeutics ↗

November 05, 2025

Via Benzinga

Kymera Therapeutics Inc (NASDAQ:KYMR) Q3 2025 Earnings: Clinical Progress Overshadows Financial Miss ↗

November 04, 2025

Via Chartmill

The Analyst Verdict: Kymera Therapeutics In The Eyes Of 6 Experts ↗

October 17, 2025

Via Benzinga

Frequently Asked Questions

Is Kymera Therapeutics, Inc. - Common Stock publicly traded?

Yes, Kymera Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Kymera Therapeutics, Inc. - Common Stock trade on?

Kymera Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Kymera Therapeutics, Inc. - Common Stock?

The ticker symbol for Kymera Therapeutics, Inc. - Common Stock is KYMR on the Nasdaq Stock Market

What is the current price of Kymera Therapeutics, Inc. - Common Stock?

The current price of Kymera Therapeutics, Inc. - Common Stock is 87.53

When was Kymera Therapeutics, Inc. - Common Stock last traded?

The last trade of Kymera Therapeutics, Inc. - Common Stock was at 05/11/26 09:41 AM ET

What is the market capitalization of Kymera Therapeutics, Inc. - Common Stock?

The market capitalization of Kymera Therapeutics, Inc. - Common Stock is 4.84B

How many shares of Kymera Therapeutics, Inc. - Common Stock are outstanding?

Kymera Therapeutics, Inc. - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.